SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-013898
Filing Date
2020-11-16
Accepted
2020-11-16 17:01:13
Documents
72
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q hepa-20200930x10q.htm 10-Q 1438244
2 EX-31.1 hepa-20200930ex31126c14d.htm EX-31.1 10867
3 EX-31.2 hepa-20200930ex3122d7546.htm EX-31.2 10053
4 EX-32.1 hepa-20200930ex321aa7c15.htm EX-32.1 5896
5 EX-32.2 hepa-20200930ex32261de38.htm EX-32.2 5581
6 GRAPHIC hepa-20200930x10q002.jpg GRAPHIC 4347
  Complete submission text file 0001558370-20-013898.txt   7339424

Data Files

Seq Description Document Type Size
7 EX-101.INS hepa-20200930.xml EX-101.INS 1714347
8 EX-101.SCH hepa-20200930.xsd EX-101.SCH 51406
9 EX-101.CAL hepa-20200930_cal.xml EX-101.CAL 43454
10 EX-101.DEF hepa-20200930_def.xml EX-101.DEF 241214
11 EX-101.LAB hepa-20200930_lab.xml EX-101.LAB 483262
12 EX-101.PRE hepa-20200930_pre.xml EX-101.PRE 379499
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36856 | Film No.: 201318125
SIC: 2834 Pharmaceutical Preparations